LENSAR, Inc. (LNSR) vs Sensus Healthcare, Inc. (SRTS)

LENSAR, Inc. and Sensus Healthcare, Inc. are both Medical Devices companies. LENSAR, Inc. is the larger, with a market value of $67.6M against $48.1M — 1.4× the size. Sensus Healthcare, Inc. has negative trailing earnings, so its P/E is not meaningful; LENSAR, Inc. trades at 3.9×. LENSAR, Inc. grew revenue faster over the last twelve months: 3.26% against −53.4%. LENSAR, Inc. has the higher net margin (57.6% vs −88.5%) and the lower return on invested capital (−379.0% vs −38.2%). Across the 17 metrics below, LENSAR, Inc. leads on 12 and Sensus Healthcare, Inc. on 5.

Valuation

Metric LNSR SRTS Medical Devices median
P/E 3.89 n/m 25.58
P/S 1.13 2.75 2.54
P/B 4.55 1.30 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 1.01 2.21 2.72
Earnings yield 25.68% (32.19%) (12.82%)
Free cash flow yield (10.91%) (14.50%) (8.18%)

Profitability

Metric LNSR SRTS Medical Devices median
Gross margin 48.34% 36.39% 57.76%
Operating margin (13.48%) (75.72%) (15.07%)
Net margin 57.57% (88.45%) (14.45%)
Free cash flow margin (12.29%) (39.82%) (3.88%)
Return on equity (851.75%) (34.83%) (10.35%)
Return on assets 49.58% (30.94%) (17.26%)
Return on invested capital (379.01%) (38.22%) (5.27%)

Growth

Metric LNSR SRTS Medical Devices median
Revenue growth (TTM) 3.26% (53.39%) 10.41%
EPS growth (last fiscal year) (5.13%) (214.63%) 28.17%
Revenue growth, 5-year CAGR 17.24% 23.47% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LNSR SRTS Medical Devices median
Debt to equity 0.00 0.00 0.04
Current ratio 2.39 8.71 2.74
Net debt to EBITDA 0.89 2.28 0.54

Dividend

Metric LNSR SRTS Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric LNSR SRTS Medical Devices median
Market cap 67.57m 48.07m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack